Drugmakers haven't been able to reach a settlement with the cities and counties suing them over the opioid epidemic.
Hundreds of cities and counties have sued to hold opioid makers accountable for the addiction epidemic. Now the feds are getting involved.
Pharmacy giant Walgreens Boots Alliance, which already owns a quarter of drug wholesaler AmerisourceBergen, may want it all.
AmerisourceBergen has received a grand jury subpoena to supply info to the DOJ about its testing of a syringe made at its PharMEDium lab in Tennessee.
AmerisourceBergen has added $50 million more to resolve a DOJ probe into sales of cancer meds, taking its total in the matter to $885 million.
AmerisourceBergen will extend its reach with an $815 million deal to buy independent drug distributor H. D. Smith.
Facing a rash of lawsuits claiming aggressive opioid marketing led to a nationwide epidemic, Purdue Pharma is reportedly initiating settlement talks.
AmerisourceBergen's costs to resolve federal litigation tied to syringe sold from an unregistered facility may reach $835 million
Generic drug prices have continued their downward spiral, but one distributor sees light at the end of the tunnel.
Investors are demanding change at top drug distributors after an investigation exposed lax controls and lots of Capitol Hill arm-twisting.